28 results
8-K
EX-99.1
GOSS
Gossamer Bio Inc
12 Mar 24
Gossamer Bio Announces Appointment of Steven D. Nathan, M.D., and Skye Drynan
4:01pm
medical associations, including the American Thoracic Society, the American College of Chest Physicians, and the International Society for Heart and Lung
8-K
EX-99.1
GOSS
Gossamer Bio Inc
9 Nov 23
Gossamer Bio Announces Third Quarter 2023 Financial Results and Provides Business Update
7:31am
Respiratory Society International Congress 2023. These data provide encouraging clinical evidence of seralutinib's ability to improve the pulmonary … , sub-study of the successful Phase 2 TORREY Study of seralutinib in patients with PAH was presented in September at the European Respiratory Society
8-K
EX-99.1
GOSS
Gossamer Bio Inc
3 Nov 22
Gossamer Bio Announces Third Quarter 2022 Financial Results and Provides Business Update
4:00pm
developed preclinical programs presented at recent medical conferences:
◦International Cytokine & Interferon Society (September 2022):
Identification … Models
Poster highlighting a third internally developed program to be presented at the upcoming Society for Immunotherapy of Cancer, or SITC 2022
8-K
EX-99.1
31z1xksp
9 Aug 21
Gossamer Bio Announces Second Quarter 2021 Financial Results and Provides Corporate Update
4:27pm
8-K
EX-99.1
s6aqq8z s587ruci
6 May 21
Gossamer Bio Announces First Quarter 2021 Financial Results and Provides Corporate Update
8:06am
8-K
EX-99.1
pc4mjjq37s h070d0
10 Nov 20
Gossamer Bio Announces Third Quarter 2020 Financial Results and Provides Corporate Update
4:14pm
424B5
w8zxgr4 t2
19 May 20
Prospectus supplement for primary offering
5:11pm
424B5
w9h0rmb46789aol6gj
19 May 20
Prospectus supplement for primary offering
5:08pm
424B5
068 do7r3pw
18 May 20
Prospectus supplement for primary offering
4:16pm
424B5
e36dv9muwu4r
18 May 20
Prospectus supplement for primary offering
4:11pm
8-K
EX-99.1
29eau 256tlz8jp7
12 May 20
Gossamer Bio Announces First Quarter 2020 Financial Results and Provides Corporate Update
4:18pm
8-K
EX-99.1
r20md6bpvd26
12 Nov 19
Gossamer Bio Announces Third Quarter 2019 Financial Results
4:10pm
10-K
0c63 anb96aa7i
22 Mar 19
Annual report
4:45pm